RAVULIZUMAB vs REGADENOSON: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RAVULIZUMAB vs REGADENOSON: Safety Overview
| Metric | RAVULIZUMAB | REGADENOSON |
|---|---|---|
| Total FAERS Reports | 118 | 3,071 |
| Deaths Reported | 11 | 84 |
| Death Rate | 9.3% | 2.7% |
| Hospitalizations | 89 | 321 |
| Average Patient Age | 48.4 yrs | 68.1 yrs |
| % Female Patients | 56.3% | 58.6% |
| FDA Approval Date | N/A | Apr 10, 2008 |
| Manufacturer | Alexion Pharmaceuticals Inc. | Apotex Corp. |
| Route | INTRAVENOUS | INTRAVENOUS |
| Marketing Status | N/A | Prescription |